Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Potent, selective and orally active ETA antagonist from Zeneca

July 8, 1997

Agent for restenosis in preclinical development at CV Therapeutics

July 7, 1997

New cardiovascular agent in development at CV Therapeutics

July 7, 1997

New agents for tachycardia from CV Therapeutics

July 7, 1997

RPR licenses Dilacor XR to Watson

July 7, 1997

Sublingual captopril and nifedipine compared in patients with hypertensive crises

July 7, 1997

Garlic has beneficial effects in model of volume overload heart failure

July 7, 1997

Roche's T-type calcium channel blocker receives European approval

July 3, 1997

Novel antifibrillatory agent: DP-16

July 3, 1997

Pharmacological profile of BMS-186716 characterized

July 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...